Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LEVALBUTEROL HYDROCHLORIDE
- Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
- Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults
- Aerosolized Beta-Agonist Isomers in Asthma
- A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
- COPD Assessment and Management Bundle Versus Usual Care
- Study of Bronchodilation Effects of Cetirizine
- A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
- Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma
- Effect of Nebulized Bronchodilators on Heart Rate
- A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
- Effect of Brovana and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)
- Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol
- Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects
- Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD)
- Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma
- Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma
- A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma
- Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects
- Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma
- Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)
- Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
- Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD
- A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
- A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation
- Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol
- Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma
- Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB
- Continuous Levalbuterol for Treatment of Status Asthmaticus in Children
- Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
- Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
- Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
- Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma
Clinical trials list
click for details